PLUS1
1.70
-0.10 (-5.56%)
-0.10 (-5.56%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Savara Inc | SVRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.10 | -5.56% | 1.70 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.84 | 1.70 | 1.9002 | 1.70 | 1.80 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.69 | 2.09 | 0.40 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,164 | 454,384 | $ 1.75 | $ 797,392 | 476,488 | 0.9952 - 3.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:54 | 3 | $ 1.70 | USD |
Savara Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 92.04M | 54.14M | 53.23M | $ - | $ - | -1.96 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Savara News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/23/2021 | 09:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/16/2021 | 09:49 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 1/19/2021 | 16:22 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 1/06/2021 | 09:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/17/2020 | 12:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/17/2020 | 12:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/17/2020 | 12:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SVRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.73 | 2.25 | 1.60 | 1.97 | 1,343,389 | -0.03 | -1.73% |
| 1 Month | 1.52 | 2.25 | 1.45 | 1.90 | 775,772 | 0.18 | 11.84% |
| 3 Months | 1.30 | 2.25 | 1.08 | 1.64 | 563,788 | 0.40 | 30.77% |
| 6 Months | 1.51 | 2.25 | 0.9952 | 1.50 | 380,956 | 0.19 | 12.58% |
| 1 Year | 2.41 | 3.17 | 0.9952 | 1.89 | 349,182 | -0.71 | -29.46% |
| 3 Years | 11.51 | 14.06 | 0.69 | 4.30 | 430,243 | -9.81 | -85.23% |
| 5 Years | 7.50 | 17.1868 | 0.69 | 4.74 | 366,904 | -5.80 | -77.33% |
Savara Description
| Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases. It offers products such as AeroVanc, for the treatment of persistent methicillin-resistant staphylococcus aureus and lung infection in cystic fibrosis patients; Molgradex, for the treatment of autoimmune pulmonary alveolar proteinosis and Aironite, an inhaled nebulized sodium nitrite solution to treat heart failure with preserved ejection fraction. All the business activity of the firm is functioned through the region of United States. |
